We have located links that may give you full text access.
The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial.
Clinical Infectious Diseases 2019 Februrary 17
BACKGROUND: Oral vaccines have lower efficacy in developing compared to developed countries. Poor water, sanitation and hygiene (WASH) may contribute to reduced oral vaccine immunogenicity.
METHODS: We conducted a cluster-randomized 2x2 factorial trial in rural Zimbabwe (NCT01824940). Pregnant women and their infants were eligible if they lived in clusters randomized to: 1) Standard-of-care (52 clusters); 2) Improved infant feeding (53 clusters); 3) WASH: ventilated improved pit latrine, two hand-washing stations, liquid soap, chlorine, infant play space, hygiene counseling (53 clusters); or 4) Feeding+WASH (53 clusters). This sub-study compared oral rotavirus vaccine seroconversion (primary outcome), and seropositivity and geometric mean titre (GMT) (secondary outcomes), in WASH versus non-WASH infants by intention-to-treat analysis.
RESULTS: We included 801 infants with documented rotavirus vaccine receipt and post-vaccine titre measurements (329 from 84 WASH clusters; 472 from 102 non-WASH clusters); 328 infants with pre-vaccination titres were included in the primary outcome. 33/109 (30.3%) infants in the WASH group seroconverted following rotavirus vaccination, compared to 43/219 (19.6%) in the non-WASH group (absolute difference 10.6% (95%CI 0.54, 20.7); p=0.031). In the WASH versus non-WASH groups, 90/329 (27.4%) versus 107/472 (22.7%) were seropositive post-vaccination (absolute difference 4.7% (95%CI -1.4, 10.8; p=0.130) and anti-rotavirus GMT was 18.4U/mL (95% CI 15.6, 21.7) versus 14.9U/mL (95% CI 13.2, 16.8); p=0.072. After restricting analyses to infants who received both doses of rotavirus vaccine, the effect of WASH on seroconversion was greater (absolute difference 13.7% (95%CI 2.0, 25.4); p=0.016).
CONCLUSIONS: Improvements in household WASH led to modest but significant increases in seroconversion to oral rotavirus vaccine in rural Zimbabwean infants.
METHODS: We conducted a cluster-randomized 2x2 factorial trial in rural Zimbabwe (NCT01824940). Pregnant women and their infants were eligible if they lived in clusters randomized to: 1) Standard-of-care (52 clusters); 2) Improved infant feeding (53 clusters); 3) WASH: ventilated improved pit latrine, two hand-washing stations, liquid soap, chlorine, infant play space, hygiene counseling (53 clusters); or 4) Feeding+WASH (53 clusters). This sub-study compared oral rotavirus vaccine seroconversion (primary outcome), and seropositivity and geometric mean titre (GMT) (secondary outcomes), in WASH versus non-WASH infants by intention-to-treat analysis.
RESULTS: We included 801 infants with documented rotavirus vaccine receipt and post-vaccine titre measurements (329 from 84 WASH clusters; 472 from 102 non-WASH clusters); 328 infants with pre-vaccination titres were included in the primary outcome. 33/109 (30.3%) infants in the WASH group seroconverted following rotavirus vaccination, compared to 43/219 (19.6%) in the non-WASH group (absolute difference 10.6% (95%CI 0.54, 20.7); p=0.031). In the WASH versus non-WASH groups, 90/329 (27.4%) versus 107/472 (22.7%) were seropositive post-vaccination (absolute difference 4.7% (95%CI -1.4, 10.8; p=0.130) and anti-rotavirus GMT was 18.4U/mL (95% CI 15.6, 21.7) versus 14.9U/mL (95% CI 13.2, 16.8); p=0.072. After restricting analyses to infants who received both doses of rotavirus vaccine, the effect of WASH on seroconversion was greater (absolute difference 13.7% (95%CI 2.0, 25.4); p=0.016).
CONCLUSIONS: Improvements in household WASH led to modest but significant increases in seroconversion to oral rotavirus vaccine in rural Zimbabwean infants.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app